Alseres Pharmaceuticals, Inc. (ALSE)

USD 0.01

(100.0%)

Revenue Summary of Alseres Pharmaceuticals, Inc.

  • Alseres Pharmaceuticals, Inc.'s latest annual revenue in 2013 was 473.73 Thousand USD , down -10.74% from previous year.
  • Alseres Pharmaceuticals, Inc.'s latest quarterly revenue in 2014 Q2 was 18.43 Thousand USD , down 0.0% from previous quarter.
  • Alseres Pharmaceuticals, Inc. reported a annual revenue of 530.72 Thousand USD in annual revenue 2012, down 0.0% from previous year.
  • Alseres Pharmaceuticals, Inc. reported a annual revenue of - USD in annual revenue 2011, down 0.0% from previous year.
  • Alseres Pharmaceuticals, Inc. reported a quarterly revenue of 18.43 Thousand USD for 2014 Q2, down 0.0% from previous quarter.
  • Alseres Pharmaceuticals, Inc. reported a quarterly revenue of 18.43 Thousand USD for 2013 Q2, down 0.0% from previous quarter.

Annual Revenue Chart of Alseres Pharmaceuticals, Inc. (2013 - 1989)

Historical Annual Revenue of Alseres Pharmaceuticals, Inc. (2013 - 1989)

Year Revenue Revenue Growth
2013 473.73 Thousand USD -10.74%
2012 530.72 Thousand USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%
2005 - USD 0.0%
2004 - USD 0.0%
2003 - USD 0.0%
2002 - USD 0.0%
2001 - USD -100.0%
2000 2.00 USD -100.0%
1999 200 Thousand USD 100.0%
1998 100 Thousand USD 0.0%
1997 100 Thousand USD -50.0%
1996 200 Thousand USD -50.0%
1995 400 Thousand USD 0.0%
1994 400 Thousand USD -33.33%
1993 600 Thousand USD -72.73%
1992 2.2 Million USD -58.49%
1991 5.3 Million USD -5.36%
1990 5.6 Million USD 124.0%
1989 2.5 Million USD 525.0%

Peer Revenue Comparison of Alseres Pharmaceuticals, Inc.

Name Revenue Revenue Difference
Burzynski Research Institute, Inc. - USD -Infinity%
Arch Therapeutics, Inc. 75.72 Thousand USD -525.601%
Evofem Biosciences, Inc. 18.21 Million USD 97.4%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
Santhera Pharmaceuticals Holding AG 122.95 Million USD 99.615%
Qrons Inc. - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
Neon Bloom, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 1.93 Million USD 75.48%
ProtoKinetix, Incorporated - USD -Infinity%
Skye Bioscience, Inc. - USD -Infinity%
Eiger BioPharmaceuticals, Inc. 15.77 Million USD 96.997%
Nanobac Pharmaceuticals, Incorporated 17.62 Thousand USD -2588.44%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 21.47 Million USD 97.794%
Intellipharmaceutics International Inc. 65.72 Thousand USD -620.743%
Propanc Biopharma, Inc. - USD -Infinity%
Mesoblast Limited 5.9 Million USD 91.973%
Marizyme, Inc. 645.81 Thousand USD 26.646%
Genus plc 668.8 Million USD 99.929%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 99.807%
Therapeutic Solutions International, Inc. 98.99 Thousand USD -378.544%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD -15.497%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD -517.149%
IMV Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. 39.51 Thousand USD -1098.77%
MultiCell Technologies, Inc. 49.32 USD -960423.114%
ONE Bio Corp. 52.29 Million USD 99.094%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 49.72 Million USD 99.047%
Arno Therapeutics, Inc. - USD -Infinity%
EV Biologics, Inc. 48.9 Thousand USD -868.773%
Q BioMed Inc. 284.35 Thousand USD -66.6%
Emmaus Life Sciences, Inc. 29.59 Million USD 98.399%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Biomind Labs Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 145.09 Million USD 99.674%
Provectus Biopharmaceuticals, Inc. 557.71 Thousand USD 15.058%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Oncotelic Therapeutics, Inc. 70 Thousand USD -576.757%
GlobeStar Therapeutics Corporation - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. 658.5 Thousand USD 28.059%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. - USD -Infinity%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 14.69 Billion USD 99.997%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 999.00 USD -47320.42%
Enzolytics Inc. 52.79 Thousand USD -797.284%
Agentix Corp. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 608.52 Thousand USD 22.151%
MetaStat, Inc. - USD -Infinity%
argenx SE 1.22 Billion USD 99.961%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. 140.24 Thousand USD -237.795%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. 617.38 Thousand USD 23.268%
Zenith Capital Corp. - USD -Infinity%
Genscript Biotech Corporation 839.52 Million USD 99.944%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. - USD -Infinity%
WPD Pharmaceuticals Inc. - USD -Infinity%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Kadimastem Ltd - USD -Infinity%
Helix BioMedix, Inc. 997.72 Thousand USD 52.519%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 48.35 Million USD 99.02%
BioStem Technologies, Inc. 16.68 Million USD 97.161%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
Regen BioPharma, Inc. 236.56 Thousand USD -100.258%
Regen BioPharma, Inc. 236.56 Thousand USD -100.258%
NovAccess Global Inc. - USD -Infinity%
Affymax, Inc. 1.36 Million USD 65.396%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
CytoDyn Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
SYBLEU INC 11.69 Thousand USD -3950.359%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
International Stem Cell Corporation 7.78 Million USD 93.918%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 13 Thousand USD -3544.077%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. - USD -Infinity%
Neutra Corp. 39.53 Thousand USD -1098.285%
Windtree Therapeutics, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD 85.774%
Coeptis Therapeutics, Inc. - USD -Infinity%
IXICO plc 6.66 Million USD 92.892%
IntelGenx Technologies Corp. 1.03 Million USD 54.405%
Gelesis Holdings, Inc. 25.76 Million USD 98.161%
CSL Limited 14.8 Billion USD 99.997%
Cellectis S.A. 755 Thousand USD 37.254%